Concord Medical Services Holdings Ltd cash flow statement CCM

Annual Quarterly

In fiscal 2025, which ended Dec 31, 2025, Concord Medical Services Holdings Ltd used $28.9 million of cash from operations, up 47.0% from the year before. It spent $8.1 million on capital expenditures. Free cash flow was negative, at -$36.9 million.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.

Line	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020	FY 2019 Dec 31, 2019	FY 2018 Dec 31, 2018	FY 2017 Dec 31, 2017	FY 2015 Dec 31, 2015
Operating
Depreciation and amortization	15 +27.4%	12 +0.4%	12 -10.0%	13 +27.5%	10 +19.6%	8 +32.4%	6 +7.2%	6 -53.5%	13 -24.1%	21 -24.4%
Stock-based compensation	—	—	—	1 -62.8%	2 -27.1%	3 +6.8%	3 +82.6%	2 -9.4%	2 +47.9%	1 +5.3%
Operating cash flow	-29 +47.0%	-54 -39.9%	-39 -24.0%	-31 +44.3%	-56 -60.1%	-35 -25.5%	-28 -399.8%	-6 -236.7%	4	-27 -134.2%
Investing
Capital expenditures	8 -61.0%	21 +29.8%	16 -50.8%	32 -26.2%	44 +70.0%	26 -23.0%	33 +38.8%	24 +71.7%	14 +23.4%	7 -11.1%
Investing cash flow	8 +109.5%	-81 -1110.7%	-7 +61.0%	-17 +80.6%	-89 -8.5%	-82 +46.8%	-154 -5.8%	-145 -202.4%	-48	-60 -230.5%
Financing
Debt issued	14 -94.8%	263 +1595.3%	15 -74.7%	61 +1.0%	61 -53.8%	131 -2.1%	134 +95.3%	69 +59.5%	43 +1714.2%	53 +12.7%
Debt repaid	62 -67.5%	191 +17796.3%	1 -96.3%	29 -11.7%	32 -12.8%	37 +1.6%	36 -50.3%	73 +446.6%	13 -53.6%	54 +21.9%
Short-term debt issued	51 -25.7%	69 +45.4%	48 +50.8%	32 +59.3%	20 -82.6%	113 +176.7%	41 -61.2%	106 +134.8%	45 -37.2%	36 +2381.0%
Short-term debt repaid	62 +26.6%	49 -20.9%	62 +117.7%	29 +638.9%	4 -97.5%	158 +148.0%	64 -49.4%	126 +157.3%	49 -50.9%	0 -97.5%
Dividends paid	—	—	—	—	—	—	—	0	0 -100.0%	—
Stock buybacks	—	—	—	—	—	—	—	0	0	3 +216.8%
Financing cash flow	28 -82.0%	157 +332.6%	36 -34.7%	56 -44.9%	101 -42.2%	174 +136.6%	74 -57.9%	175 +485.6%	30	91 +197.6%
Change in cash
Effect of exchange rate	—	—	—	—	-1 -83.5%	-0 -337.3%	0	—	—	—
Net change in cash	9 -56.0%	20 +306.9%	-10 -15507.9%	0 +100.1%	-45 -179.1%	57 +152.8%	-108	—	—	—
Free cash flow	-37 +50.9%	-75 -37.0%	-55 +13.9%	-64 +36.4%	-100 -64.3%	-61 +0.8%	-61 -107.0%	-30 -199.4%	-10	-34 -148.6%
Per share
Free cash flow per share	-0.28 +50.9%	-0.57 -37.0%	-0.42 +13.9%	-0.49	—	—	—	—	—	-0.26 -148.9%
Dividend per share	—	—	—	—	—	—	—	—	—	0.00
Shareholder returns
Returned to shareholders	—	—	—	—	—	—	—	0	0	3
Ratios
Free cash flow margin	-56.82%	-146.43%	-74.81%	-97.68%	-144.04%	-233.84%	-306.17%	-106.97%	-19.50%	-36.16%
Capital expenditures to revenue	12.40%	40.25%	21.70%	49.54%	62.95%	98.78%	166.45%	86.75%	27.57%	7.75%
Stock-based compensation to revenue	—	—	—	1.31%	3.31%	12.12%	14.73%	5.83%	3.52%	1.31%

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry: Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
Listed as: CCM (NYSE)
Incorporated in: Cayman Islands
Headquarters: Chaoyang District, Beijing
SEC filer status: Non-accelerated filer
SEC CIK: 1472072

Other Services-Offices & Clinics of Doctors of Medicine companies

All 12 Services-Offices & Clinics of Doctors of Medicine companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.